DNA Sequencing Market Research Report - Forecast to 2030

DNA Sequencing Market Research Report: By Type (Workflow Products and Others), Product (Sequencing Services and Others), Technology (Semiconductor Sequencing and Others), Application (Diagnostics and Others), End- Forecast Till 2030

ID: MRFR/LS/4319-HCR | October 2022 | Region: Global | 90 Pages         

DNA Sequencing Market

DNA Sequencing Market is expected grow USD 4870 Million at a CAGR 11.2% during the forecast 2022 - 2030

Segmentation

By Product Consumable Instrument Service
By Application Diagnostics Biomarkers & Cancer Reproductive Health Personalized Medicine Forensics
By Technology Semiconductor Sequencing Sequencing By Ligation Pyrosequencing
By End-User Academic & Government Research Institutes Pharmaceutical Companies Biotechnology Companies Hospitals & Clinics

Key Players

  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
  • Perkin Elmer Inc.
  • Pacific Biosciences of California Inc.
  • BGI

Drivers

  • Increasing research and development
  • Growing prevalence of cancer
  • Growth in liquid biopsy applications
Speak to Analyst Request a Free Sample

DNA Sequencing Market Overview:


The DNA Sequencing Market is expected to boost USD 4870 million during the estimated the forecasting year of 2022-2030. The market is estimated to grow at 11.2% CAGR by 2030.


DNA sequencing is a method that uses extensive parallelization to sequence many DNA strands. Both Sanger's and non-sanger methods of sequencing are used in this sequencing. DNA sequencing has advantages over microarray and other genetic analysis techniques, including low cost, high accuracy & speed, and exact findings even with small sample input. Applications for DNA sequencing include biomarker identification, cancer research, customized medicine, forensics, and others. It has streamlined nucleotide analysis and has superseded traditional genomics technologies, like genotyping, microarray, and others.


Due to the boom in sequencing applications and growth in technological developments in DNA sequencing, the demand for DNA sequencing has dramatically grown. Additionally, a boost in worldwide genome mapping efforts and research and development spending are two factors driving the market's expansion. The development of DNA sequencing technology, its expanding use in clinical diagnostics and drug discovery, and rising research and development spending are some drivers boosting the market growth. Diagnostics, customized medicine, biomarkers, forensics, reproductive health, and other fields can all benefit from DNA sequencing. Developing cancer diagnostics and therapies using DNA sequencing technology has enormous potential.


The next-generation sequencing market is being pushed by elements including the expansion of NGS's applications, its affordability, accuracy, and speedy replacement of older technologies in the drug development industry. The benefit of this technology is that it is substantially quicker, significantly cheaper, and requires significantly less DNA, which aids in the segment's overall growth.


COVID 19 Analysis:


In the years 2019 and 2020 there was an increasing number of COVID cases all over the world. The condition has affected the economy of several countries. The rapid genome sequencing techniques were carried out to monitor the spread of the viruses, which has also helped in guiding patients with specific treatments. The technique has offered huge help in bringing the widespread coronavirus under control. 


The COVID sequence test carried out in June 2020 which was able to sequence the full genome of the coronavirus helped to understand the virus better. This has led in the right direction of manufacturing the vaccination for COVID. Additionally, the Nova sequencing was able to process over 3000 blood samples under 24 hours to determine the infection.


Market dynamics:


Drivers:


In recent years, surging clinical syndromes are suspected to be viral infections, however, isolating the causing agent is becoming difficult using the traditional culture methods or molecular methods. The random sequencing techniques of viral genomes have helped in discovering new viruses in the past. Such techniques are still gaining popularity in recent times. This primary role of identifying viruses has increased the DNA sequencing market value.


The DNA sequencing market is experiencing tremendous growth in agriculture. By assessing the genetic and environmental factors, the disease resisting quality, drought tolerance, and yield are tracked, and utilizing the molecular markers of the genetic determinants has increased the efficiency in crop breeding and yielded other agricultural benefits.


Market Opportunities:


The advent of technologies in the market that performs the specified task with minimal time constraint has offered a significant opportunity for the growth of the DNA sequencing market value. In the year 2019, the Ion torrent Genexus system was introduced into the market which is a fully integrated system that is capable of reporting the results within a day economically. Such inventions in the market have bolstered the overall DNA sequencing market growth.


The academic and research institutions are considered as the major end-user which intensively utilize the DNA sequencing procedures. Additionally, the pharmaceutical companies are showcasing surging demand in the DNA sequencing market growth. Hence the varied application end users of the market are the major reasons for the growth of the DNA Sequencing market value.


Restraints:


The expensive reagents are affecting the growth of the DNA sequencing market growth in recent years. Although the costs incurred in the overall procedures have been reduced, the rising prices in manufacturing these reagents and kits have a significant impact on the growth of the DNA sequencing industry.


The raw data produced by the sequencing technologies have to be assembled as a complete genome. The computational challenges involved in the process of converting this raw data are considered as the major restraining factor in the DNA sequencing market growth. The occurrence of repetitive sequences hinders achieving the complete genome assemblies. Such issues in the industry affect the overall growth.


Challenges:


The ethical issues that are associated with acquiring the DNA sequences or information of the individual are considered as the primary challenge in the DNA Sequencing industry. The information acquired is share and stored in electronic devices which can be handled by the health insurance companies against the individual. Privacy issues and ethical issues related to the DNA sequencing industry are considered as the primary restraining factors in the growth of the DNA sequencing industry.


In the Postnatal genome sequencing technique, determining the fetal genome can be quite difficult if there is not sufficient fetal DNA in the mother’s blood sample. Such procedures are vital in medical procedures however, regular failing of these procedures are considered as the primary restraining factors of the DNA Sequencing industry.


Cumulative Growth Analysis:


The tremendous growth of the DNA sequencing market is due to consecutive successes in the modern animal farming segment. The DNA sequencing procedures are intensively utilized in animal and plant breeding were choosing the finest animals for breeding requires deep information of their genetics. Techniques like genome sequencing, genome-wide association, genotyping are increasingly gaining popularity in recent years. The recent successes like acquiring higher quality milk and higher yield, supreme quality of beef, the overall health of the cattle are the primary reasons that are driving the DNA Sequencing market growth.


On the other hand, In Jan 2020, Harvard University has received funding of about USD 23 million in carrying out researches in the industry. The researches in combining the NGS technology with the enzymatic DNA synthesis into a single device have been carried out for over 4 years now. 


Value chain analysis:


Genomics has entered the medical industry only 50 years ago, however has experienced tremendous technological development in recent times. The traditional two-dimensional chromatography was very time-consuming. However, the advancements in technology have brought fluorescent-based sequencing procedures that can be performed quite easily and are very less time-consuming. Over 100,000 billion sequencing procedures are carried out in laboratories each year while only an entire genome costs only a few thousand dollars currently. The reduced costs and time is taken for the procedure are the primary reasons for the DNA Sequencing market growth.


The demand for the high-throughput sequencing method is increasing in recent years. This next-generation DNA sequencing method is capable of performing thousands of sequencing simultaneously at lower costs. DNA sequencing is generally used for identifying the type of cancer in the patient and helps the doctors in assisting the patient with more suitable cancer treatment. The COVID-19 has increased the demand for NGS technology which helps in monitoring the spread of the virus and guidance in treatment in the future. 


DNA Sequencing Market Segment Overview:


Based on Product:



  • Consumable

  • Instrument

  • Service


Based on Application:



  • Diagnostics

  • Biomarkers & Cancer

  • Reproductive Health

  • Personalized Medicine

  • Forensics

  • Others


Based on Technology:



  • Sequencing by Synthesis

  • Ion Semiconductor Sequencing

  • Sequencing by Ligation

  • Pyrosequencing

  • Single-molecule Real-time Sequencing

  • Chain Termination Sequencing

  • Nanopore Sequencing


Based on End User:



  • Academic & Government Research Institutes

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Hospitals & Clinics


DNA Sequencing Market Regional Analysis:


Currently, North America is holding the highest DNA Sequencing market share owing to the presence of several key market players and increasing investments in R&D development. The US and Canadian government has increased the initiatives to boost the market growth. The personalized Onco-Genomics program established by the BC cancer foundation has improved the treatments related to cancer. Therefore, North America is likely to project the highest revenue among other countries accounting for over 44.3%.


On the other hand, Asia-pacific regions are showcasing lucrative growth rates in recent years. The increasing customer base has propelled international firms to expand their businesses with strategic initiatives. A prominent firm in California has risen over USD 75 million for the expansion of the tabletop DNA sequencer to support the ongoing crisis – COVID 19.


Competitive landscape:



  • Agilent Technologies, Inc.

  • Thermo Fisher Scientific, Inc.

  • Illumina, Inc.

  • QIAGEN

  • F. Hoffmann-La Roche Ltd.

  • Oxford Nanopore Technologies Ltd.

  • Macrogen, Inc.

  • Perkin Elmer, Inc.

  • Pacific Biosciences of California, Inc.

  • BGI

  • Bio-Rad Laboratories, Inc.

  • Myriad Genetics

  • PierianDx

  • Intrexon Bioinformatics Germany GmbH

  • Eurofins Scientific


Recent Developments:



  • Due to increased financing and support initiatives by governmental and non-governmental organizations, North America dominated the industry, particularly in the United States.

  • The main driving forces behind DNA sequencing in the nation are the rising uptake of cutting-edge technology, favorable government assistance, and associated legislation.

  • The launches and advances are significant drivers of the category growth, together with the benefits and rising demand for this technology.


Report overview:


This report has covered:



  • Market overview

  • COVID 19 Analysis

  • Market dynamics

  • Cumulative growth analysis

  • Value chain analysis

  • Segment overview

  • Regional analysis

  • Competitive landscape

  • Recent developments


Segmentation Table:


Based on Product:



  • Consumable

  • Instrument

  • Service


Based on Application:



  • Diagnostics

  • Biomarkers & Cancer

  • Reproductive Health

  • Personalized Medicine

  • Forensics

  • Others


Based on Technology:



  • Sequencing by Synthesis

  • Ion Semiconductor Sequencing

  • Sequencing by Ligation

  • Pyrosequencing

  • Single-molecule Real-time Sequencing

  • Chain Termination Sequencing

  • Nanopore Sequencing


Based on End User:



  • Academic & Government Research Institutes

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Hospitals & Clinics



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4870 Million
  CAGR   11.2%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Product, Technology, End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Growing requirement of breeders for animals and plant production Development in technology
  • Increasing research and development
  • Growing prevalence of cancer
  • Growth in liquid biopsy applications


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The DNA sequencing market has the scope for USD 4870 Mn growth during the review period of 2022-2030.

    Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter

    Industries like biotechnology and pharmaceutical companies, clinics & hospitals, research centers & government institutes and academia, and other end-users are expected to trigger growth for the DNA sequencing market.

    Factors like development in technology, increasing research & development projects, growing prevalence of cancer, increasing demand for breeders of animals & plant production, and surge in liquid biopsy applications would dominate the growth of the DNA sequencing market.

    The Middle Eastern and African DNA sequencing market would be adversely affected by a lack of technical expertise and insufficient medical facilities.